More tools:Markets·Screener·Research·Chat

Zura Bio Limited Class A Ordinary Shares (ZURA) Financial Statements

Zura Bio Limited Class A Ordinary Shares
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG011FJXVZ5
XNAS · usd
6.03▼ 0.10 (-1.65%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close6.13
Day's Range5.90 – 6.23
52-Week Range1.88 – 7.44
Volume1.6M
Avg Volume1.3M
Share Statistics
Shares Outstanding
Employees40
ExchangeXNAS
Listed2023-03-21
Share count as of August 11, 2026
Loading Income Statement…
Key questions about Zura Bio Limited Class A Ordinary Shares (ZURA)
What is Zura Bio Limited Class A Ordinary Shares's Market Cap?
Zura Bio Limited Class A Ordinary Shares's Market Cap is $577.8M, based on as-reported figures from SEC (XBRL) filings.
What is Zura Bio Limited Class A Ordinary Shares's Enterprise Value?
Zura Bio Limited Class A Ordinary Shares's Enterprise Value is $372.6M, based on as-reported figures from SEC (XBRL) filings.
What is Zura Bio Limited Class A Ordinary Shares's EV / EBITDA?
Zura Bio Limited Class A Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Zura Bio Limited Class A Ordinary Shares's Net Income (TTM)?
Zura Bio Limited Class A Ordinary Shares's Net Income (TTM) is -$85.7M, based on as-reported figures from SEC (XBRL) filings.
What is Zura Bio Limited Class A Ordinary Shares's EBITDA?
Zura Bio Limited Class A Ordinary Shares's EBITDA is -$92.7M, based on as-reported figures from SEC (XBRL) filings.
What is Zura Bio Limited Class A Ordinary Shares's Diluted EPS (TTM)?
Zura Bio Limited Class A Ordinary Shares's Diluted EPS (TTM) is -0.89, based on as-reported figures from SEC (XBRL) filings.
What is Zura Bio Limited Class A Ordinary Shares's Net Debt?
Zura Bio Limited Class A Ordinary Shares's Net Debt is -$205.1M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other (income), net
Interest income
Other income, net
Total other (income), net
Loss before income taxes
Income tax benefit——
Net loss
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)